Adaptive Biotechnologies, Bristol-Myers deal

Adaptive and Bristol-Myers partnered to discover biomarkers that indicate response to cancer drugs. Adaptive will use its immunoSEQ immune profiling assay to identify the biomarkers that predict a res...